» Articles » PMID: 12721954

Variation in the HLA-G Promoter Region Influences Miscarriage Rates

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2003 May 2
PMID 12721954
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

The HLA-G gene is primarily expressed in placental cells that invade the maternal decidua during pregnancy. This gene encodes multiple isoforms that fulfill a variety of functions at the maternal-fetal interface throughout gestation. Recently, a null allele for the most abundant HLA-G isoform was associated with recurrent miscarriage in two independent studies, suggesting that reduced levels of the HLA-G1 protein may compromise successful pregnancy. We initiated the present study to determine whether other polymorphisms that could affect expression levels of HLA-G were associated with fetal loss in women participating in a 15-year prospective study of pregnancy outcome. We genotyped these subjects for 18 single-nucleotide polymorphisms in the 1,300 bp upstream of exon 1, 13 of which were identified as part of this study, as well as for an insertion/deletion (in/del) polymorphism in the 3' untranslated region. The 18 SNPs defined eight unique haplotypes. One polymorphism, -725C/G, was associated with fetal loss, with an increased risk for miscarriage in couples in which both partners carried the -725G allele, compared with couples not carrying this allele (odds ratio 2.76, 95% confidence interval 1.08-7.09; P=.035). Further, the G at nucleotide -725 creates a CpG dinucleotide, and we demonstrate that this CpG site is methylated on -725G alleles. Overall, this study identified extraordinary levels of variation in the 5'-upstream regulatory region of HLA-G and provides evidence for an association between a promoter-region SNP and fetal loss rates, further attesting to the novel features and critical role of this gene in pregnancy.

Citing Articles

Variation within the non-coding genome influences genetic and epigenetic regulation of the human leukocyte antigen genes.

Arumugam T, Adimulam T, Gokul A, Ramsuran V Front Immunol. 2024; 15:1422834.

PMID: 39355248 PMC: 11442197. DOI: 10.3389/fimmu.2024.1422834.


Maternal-Fetal Compatibility in Recurrent Pregnancy Loss.

Cuadrado-Torroglosa I, Garcia-Velasco J, Alecsandru D J Clin Med. 2024; 13(8).

PMID: 38673652 PMC: 11051463. DOI: 10.3390/jcm13082379.


Understanding recurrent pregnancy loss: recent advances on its etiology, clinical diagnosis, and management.

Cao C, Bai S, Zhang J, Sun X, Meng A, Chen H Med Rev (2021). 2023; 2(6):570-589.

PMID: 37724255 PMC: 10471095. DOI: 10.1515/mr-2022-0030.


Association of parental HLA-G polymorphisms with soluble HLA-G expressions and their roles on recurrent implantation failure: A systematic review and meta-analysis.

Hu L, He D, Zeng H Front Immunol. 2022; 13:988370.

PMID: 36532068 PMC: 9751038. DOI: 10.3389/fimmu.2022.988370.


HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine.

Adolf I, Almars A, Dharsee N, Mselle T, Akan G, Nguma I Genes Dis. 2022; 9(5):1220-1233.

PMID: 35873024 PMC: 9293715. DOI: 10.1016/j.gendis.2021.06.004.


References
1.
Fujii T, Ishitani A, Geraghty D . A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol. 1994; 153(12):5516-24. View

2.
Kapasi K, Albert S, Yie S, Zavazava N, Librach C . HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology. 2000; 101(2):191-200. PMC: 2327080. DOI: 10.1046/j.1365-2567.2000.00109.x. View

3.
Rebmann V, Pfeiffer K, Passler M, Ferrone S, Maier S, Weiss E . Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens. 1999; 53(1):14-22. DOI: 10.1034/j.1399-0039.1999.530102.x. View

4.
Casro M, Morales P, Martinez-Laso J, Allende L, Varela P, Garcia-Berciano M . Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival. Tissue Antigens. 2000; 56(3):232-9. DOI: 10.1034/j.1399-0039.2000.560305.x. View

5.
Hviid T, Sorensen S, Morling N . Polymorphism in the regulatory region located more than 1.1 kilobases 5' to the start site of transcription, the promoter region, and exon 1 of the HLA-G gene. Hum Immunol. 2000; 60(12):1237-44. DOI: 10.1016/s0198-8859(99)00130-5. View